Drug · DIN 02470152
HUMALOG
JUNIOR KWIKPEN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since April 6, 2018; first marketed April 6, 2018.
- Drug Identification Number (DIN)
- 02470152
- Company (DIN owner)
- Eli Lilly Canada IncToronto, Ontario, Canada
- Schedule
- Schedule D
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Insulin lispro A10AB04
- Class
- Human
- Record last updated
- September 14, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| INSULIN LISPRO | 100 UNIT | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- November 28, 2017: NOC 20087Supplement to a New Drug Submission (SNDS) · New presentation
Other DINs named HUMALOG
- DIN 02229704 · Marketed